SYRS
Syros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Margins
Gross margin
-228.8%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
879.4%
Return on equity
-115.1%
Return on assets
-227.1%
Return on invested capital
0.00x
Asset turnover
-$100.0M
Cash from operations
$1.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2024